Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population

Clinical Biochemistry

Volumn 45, Issue 3, 2012, Pages 203-206

  Yang, Zaixing ^a   Liang, Yan ^a   Qin, Baodong ^a   Li, Chang ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autoantibodies; Diagnosis; Performance; Primary biliary cirrhosis

Indexed keywords

ANTINUCLEAR ANTIBODY; MITOCHONDRION ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CENTROMERE; CHINESE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS E; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCHISTOSOMIASIS; TOXIC HEPATITIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE; MIDDLE AGED; MITOCHONDRIA; MULTIVARIATE ANALYSIS; SEX CHARACTERISTICS; TITRIMETRY;

EID: 84856443565     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.08.1146     Document Type: Article

References (31)

1. Bogdanos D.P., Baum H., Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003, 7:759-777.
2. Vergani D., Bogdanos D.P. Positive markers in AMA-negative PBC. Am J Gastroenterol 2003, 98:241-243.
3. Leung P.S., Rossaro L., Davis P.A., et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007, 46:1436-1442.
4. Bernal W., Meda F., Ma Y., Bogdanos D.P., Vergani D. Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology 2008, 47:1096-1097.
5. O'Brien C., Joshi S., Feld J.J., et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008, 48:550-556.
6. Montano-Loza A.J., Carpenter H.A., Czaja A.J. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 2008, 42:1047-1053.
7. Polymeros D., Kamberoglou D., Tzias V. Acute cholestatic hepatitis caused by Teucrium polium (golden germander) with transient appearance of antimitochondrial antibody. J Clin Gastroenterol 2002, 34(1):100-101.
8. Zuchner D., Sternsdorf T., Szostecki C., et al. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 1997, 26:1123-1130.
9. Itoh S., Ichida T., Yoshida T., et al. Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998, 13:257-265.
10. Invernizzi P., Podda M., Battezzati P.M., et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001, 34:366-372.
11. Muratori P., Muratori L., Ferrari R., et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003, 98:431-437.
12. Lindor K.D., Gershwin M.E., Poupon R., Kaplan M., Bergasa N.V., Heathcote E.J. American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
13. Agmon-Levin N., Shapira Y., Selmi C., Barzilai O., Ram M., Szyper-Kravitz M., et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010, 34:55-58.
14. Hu C., Deng C., Song G., Zhang W., Zhang S., Li X., et al. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci Jun 10 2012, Epub ahead of print.
15. Czaja A.J. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci 2011, 56:545-554.
16. Prince M., Chetwynd A., Newman W., Metcalf J.V., James O.F. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28years. Gastroenterology 2002, 123:1044-1051.
17. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
18. Czaja A.J., Homburger H.A. Autoantibodies in liver disease. Gastroenterology 2001, 120:239-249.
19. Bogdanos D.P., Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta 2011, 412:502-512.
20. Miyakawa H., Kawashima Y., Kitazawa E., et al. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J Autoimmun 2003, 21:77-82.
21. Ma Y., Okamoto M., Thomas M.G., et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002, 35:658-664. 31.
22. Baeres M., Herkel J., Czaja A.J., et al. Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002, 51:259-264.
23. Granito A., Muratori P., Muratori L., Pappas G., Cassani F., Worthington J., et al. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 2007, 26:831-838.
24. Dorner T., Feist E., Held C., Conrad K., Burmester G.R., Hiepe F. Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren's syndrome. Hepatology 1996, 24:1404-1407.
25. Czaja A.J. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging 2008, 25:219-239.
26. Czaja A.J., Donaldson P.T. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 2002, 97:2051-2057.
27. Banks S.E., Riley T.R., Naides S.J. Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease. Dig Dis Sci 2007, 52(5):1177-1182.
28. Adams L.A., Lindor K.D., Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2004, 99(7):1316-1320.
29. Gutierrez A., Chinchilla V., Espasa A., Perez-Mate0 M. Transient detection of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection. Am J Gastroenterol 1995, 90:171.
30. Gutierrez A., Chinchilla V., Espasa A., Perez-Mate0 M. Transient positivity of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection. J Hepatol 1996, 24(1):123.
31. Vergani D., Alvarez F., Bianchi F.B., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 2004, 41:677-683.